Tumorigenesis due to viral infection accounts for a high fraction of the total global cancer
burden (15–20%) of all human cancers. A comprehensive understanding of the mechanisms …

Hepatocellular carcinoma (HCC) arises in the background of chronic liver diseases,
including hepatitis and liver cirrhosis caused by hepatitis C virus (HCV) infection. It is well …

Background Chronic viral hepatitis B, C, and D are the main causes of decompensated
cirrhosis and liver cancer worldwide. Newborn HBV vaccination was implemented more …

Background and Objectives: In the early period after liver transplantation, patients are
exposed to a high rate of complications and several scores are currently available to predict …

Introduction of effective drugs in the treatment of hepatitis C virus (HCV) infection has
prompted the World Health Organization to declare a global eradication target by 2030 …

Background and study aims: Chronic hepatitis C virus (HCV) infection has always been
identified as a major health threat and a potential cause of liver cirrhosis, portal …

Abstract Background and Aim The risk of hepatocellular carcinoma (HCC) persists in a
condition of sustained virologic response (SVR) after hepatitis C virus (HCV) eradication …

The development of direct-acting antiviral (DAA) therapies in chronic HCV infection has
been associated with increased expectations regarding the prognosis of this infection in the …

Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and mainly occurs in
patients having chronic liver disease and cirrhosis. Egypt ranks the third and15th most …

Tumorigenesis due to viral infection accounts for a high fraction of the total global cancer
burden (15–20%) of all human cancers. A comprehensive understanding of the mechanisms …